Allergan Sales, LLC recalls Tazorac (tazarotene) Gel 0.05%, Rx only, packaged in a) 30g (NDC 0023-8335-03) and b) 100g (NDC 0023-8335-10) tubes, Al…
- Recall date
- May 10, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1064-2016
- FDA classification
- Class II
- Brand / firm
- Allergan Sales, LLC
- Sold / distributed
- Nationwide and Puerto Rico
Why it was recalled
Failed Content Uniformity Specifications.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Tazorac (tazarotene) Gel 0.05%, Rx only, packaged in a) 30g (NDC 0023-8335-03) and b) 100g (NDC 0023-8335-10) tubes, Allergan Inc, Irvine, CA 92612
Get recall alerts
Free email alert whenever Allergan Sales, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Allergan Sales, LLC